BMS-708163 (semagacestat)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-708163 (semagacestat), covering 2015-10-12 to 2015-10-12. Get the full timeline:
Most recent: Clinical Trial Update: A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease [Phase 2]